English
简体中文
Total: £ 56.28
Published Date: 2025-04-01 | Pages: 81 | Tables: 90 | Medical Care
The global market for Gene Delivery System was valued at US$ 11480 million in the year 2024 and is projected to reach a revised size of US$ 61870 million by 2031, growing at a CAGR of 27.6% during the forecast period.
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient"s cells instead of using drugs or surgery.
Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%.
North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019.
Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share.
This report aims to provide a comprehensive presentation of the global market for Gene Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Delivery System.
The Gene Delivery System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Segment by Type
Viral Gene Delivery System
Non-viral Gene Delivery System
Segment by Application
Neurological Diseases
Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Delivery System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Delivery System Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Gene Delivery System Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Delivery System Market Perspective (2020-2031)
2.2 Global Gene Delivery System Growth Trends by Region
2.2.1 Global Gene Delivery System Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Delivery System Historic Market Size by Region (2020-2025)
2.2.3 Gene Delivery System Forecasted Market Size by Region (2026-2031)
2.3 Gene Delivery System Market Dynamics
2.3.1 Gene Delivery System Industry Trends
2.3.2 Gene Delivery System Market Drivers
2.3.3 Gene Delivery System Market Challenges
2.3.4 Gene Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Delivery System Players by Revenue
3.1.1 Global Top Gene Delivery System Players by Revenue (2020-2025)
3.1.2 Global Gene Delivery System Revenue Market Share by Players (2020-2025)
3.2 Global Gene Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Delivery System Revenue
3.4 Global Gene Delivery System Market Concentration Ratio
3.4.1 Global Gene Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Delivery System Revenue in 2024
3.5 Global Key Players of Gene Delivery System Head office and Area Served
3.6 Global Key Players of Gene Delivery System, Product and Application
3.7 Global Key Players of Gene Delivery System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Delivery System Breakdown Data by Type
4.1 Global Gene Delivery System Historic Market Size by Type (2020-2025)
4.2 Global Gene Delivery System Forecasted Market Size by Type (2026-2031)
5 Gene Delivery System Breakdown Data by Application
5.1 Global Gene Delivery System Historic Market Size by Application (2020-2025)
5.2 Global Gene Delivery System Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Delivery System Market Size (2020-2031)
6.2 North America Gene Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Delivery System Market Size by Country (2020-2025)
6.4 North America Gene Delivery System Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Delivery System Market Size (2020-2031)
7.2 Europe Gene Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Delivery System Market Size by Country (2020-2025)
7.4 Europe Gene Delivery System Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Delivery System Market Size (2020-2031)
8.2 Asia-Pacific Gene Delivery System Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Delivery System Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Delivery System Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Delivery System Market Size (2020-2031)
9.2 Latin America Gene Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Delivery System Market Size by Country (2020-2025)
9.4 Latin America Gene Delivery System Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Delivery System Market Size (2020-2031)
10.2 Middle East & Africa Gene Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Delivery System Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Delivery System Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Delivery System Introduction
11.1.4 Biogen Revenue in Gene Delivery System Business (2020-2025)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Delivery System Introduction
11.2.4 Novartis Revenue in Gene Delivery System Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Delivery System Introduction
11.3.4 Gilead Sciences Revenue in Gene Delivery System Business (2020-2025)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Delivery System Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Delivery System Business (2020-2025)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Delivery System Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2020-2025)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Delivery System Introduction
11.6.4 Amgen Revenue in Gene Delivery System Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene Delivery System Introduction
11.7.4 Spark Therapeutics Revenue in Gene Delivery System Business (2020-2025)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Delivery System Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Delivery System Business (2020-2025)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Details
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene Delivery System Introduction
11.9.4 bluebird bio Revenue in Gene Delivery System Business (2020-2025)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Details
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene Delivery System Introduction
11.10.4 Sunway Biotech Revenue in Gene Delivery System Business (2020-2025)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Details
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene Delivery System Introduction
11.11.4 SIBIONO Revenue in Gene Delivery System Business (2020-2025)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Details
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene Delivery System Introduction
11.12.4 AnGes Revenue in Gene Delivery System Business (2020-2025)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Details
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene Delivery System Introduction
11.13.4 Orchard Therapeutics Revenue in Gene Delivery System Business (2020-2025)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Details
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene Delivery System Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene Delivery System Business (2020-2025)
11.14.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Gene Delivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Viral Gene Delivery System
Table 3. Key Players of Non-viral Gene Delivery System
Table 4. Global Gene Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Gene Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Gene Delivery System Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Gene Delivery System Market Share by Region (2020-2025)
Table 8. Global Gene Delivery System Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Gene Delivery System Market Share by Region (2026-2031)
Table 10. Gene Delivery System Market Trends
Table 11. Gene Delivery System Market Drivers
Table 12. Gene Delivery System Market Challenges
Table 13. Gene Delivery System Market Restraints
Table 14. Global Gene Delivery System Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Gene Delivery System Market Share by Players (2020-2025)
Table 16. Global Top Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System as of 2024)
Table 17. Ranking of Global Top Gene Delivery System Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Gene Delivery System Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Gene Delivery System, Headquarters and Area Served
Table 20. Global Key Players of Gene Delivery System, Product and Application
Table 21. Global Key Players of Gene Delivery System, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Gene Delivery System Revenue Market Share by Type (2020-2025)
Table 25. Global Gene Delivery System Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Gene Delivery System Revenue Market Share by Type (2026-2031)
Table 27. Global Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Gene Delivery System Revenue Market Share by Application (2020-2025)
Table 29. Global Gene Delivery System Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Gene Delivery System Revenue Market Share by Application (2026-2031)
Table 31. North America Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Gene Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Gene Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Gene Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Gene Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Gene Delivery System Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Gene Delivery System Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Gene Delivery System Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Gene Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Gene Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Gene Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Gene Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 46. Biogen Company Details
Table 47. Biogen Business Overview
Table 48. Biogen Gene Delivery System Product
Table 49. Biogen Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis Gene Delivery System Product
Table 54. Novartis Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Details
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Gene Delivery System Product
Table 59. Gilead Sciences Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Sarepta Therapeutics Company Details
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Gene Delivery System Product
Table 64. Sarepta Therapeutics Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Pharmaceuticals Company Details
Table 67. Alnylam Pharmaceuticals Business Overview
Table 68. Alnylam Pharmaceuticals Gene Delivery System Product
Table 69. Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 70. Alnylam Pharmaceuticals Recent Development
Table 71. Amgen Company Details
Table 72. Amgen Business Overview
Table 73. Amgen Gene Delivery System Product
Table 74. Amgen Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Spark Therapeutics Company Details
Table 77. Spark Therapeutics Business Overview
Table 78. Spark Therapeutics Gene Delivery System Product
Table 79. Spark Therapeutics Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 80. Spark Therapeutics Recent Development
Table 81. Akcea Therapeutics Company Details
Table 82. Akcea Therapeutics Business Overview
Table 83. Akcea Therapeutics Gene Delivery System Product
Table 84. Akcea Therapeutics Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 85. Akcea Therapeutics Recent Development
Table 86. bluebird bio Company Details
Table 87. bluebird bio Business Overview
Table 88. bluebird bio Gene Delivery System Product
Table 89. bluebird bio Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 90. bluebird bio Recent Development
Table 91. Sunway Biotech Company Details
Table 92. Sunway Biotech Business Overview
Table 93. Sunway Biotech Gene Delivery System Product
Table 94. Sunway Biotech Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 95. Sunway Biotech Recent Development
Table 96. SIBIONO Company Details
Table 97. SIBIONO Business Overview
Table 98. SIBIONO Gene Delivery System Product
Table 99. SIBIONO Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 100. SIBIONO Recent Development
Table 101. AnGes Company Details
Table 102. AnGes Business Overview
Table 103. AnGes Gene Delivery System Product
Table 104. AnGes Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 105. AnGes Recent Development
Table 106. Orchard Therapeutics Company Details
Table 107. Orchard Therapeutics Business Overview
Table 108. Orchard Therapeutics Gene Delivery System Product
Table 109. Orchard Therapeutics Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 110. Orchard Therapeutics Recent Development
Table 111. Human Stem Cells Institute Company Details
Table 112. Human Stem Cells Institute Business Overview
Table 113. Human Stem Cells Institute Gene Delivery System Product
Table 114. Human Stem Cells Institute Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 115. Human Stem Cells Institute Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Gene Delivery System Picture
Figure 2. Global Gene Delivery System Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gene Delivery System Market Share by Type: 2024 VS 2031
Figure 4. Viral Gene Delivery System Features
Figure 5. Non-viral Gene Delivery System Features
Figure 6. Global Gene Delivery System Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Gene Delivery System Market Share by Application: 2024 VS 2031
Figure 8. Neurological Diseases Case Studies
Figure 9. Cancer Case Studies
Figure 10. Others Case Studies
Figure 11. Gene Delivery System Report Years Considered
Figure 12. Global Gene Delivery System Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Gene Delivery System Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Gene Delivery System Market Share by Region: 2024 VS 2031
Figure 15. Global Gene Delivery System Market Share by Players in 2024
Figure 16. Global Top Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Gene Delivery System Revenue in 2024
Figure 18. North America Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Gene Delivery System Market Share by Country (2020-2031)
Figure 20. United States Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Gene Delivery System Market Share by Country (2020-2031)
Figure 24. Germany Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Gene Delivery System Market Share by Region (2020-2031)
Figure 32. China Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Gene Delivery System Market Share by Country (2020-2031)
Figure 40. Mexico Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Gene Delivery System Market Share by Country (2020-2031)
Figure 44. Turkey Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Biogen Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 48. Novartis Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 49. Gilead Sciences Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 50. Sarepta Therapeutics Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 51. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 52. Amgen Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 53. Spark Therapeutics Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 54. Akcea Therapeutics Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 55. bluebird bio Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 56. Sunway Biotech Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 57. SIBIONO Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 58. AnGes Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 59. Orchard Therapeutics Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 60. Human Stem Cells Institute Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
